Pegomastax africanus

Война с анестезией

WASHINGTON, D.C.; February 26, 2014 (WPVI): Zohydro ER (extended release), which is hydrocodone-based, is supposed to go on sale next month. But more than 40 health care, consumer, and addiction treatment groups have told the FDA it's too dangerous. And 29 state attorneys general say it's the next Oxycontin, and will fuel the national addiction epidemic. Почему нельзя иметь прокуратуру: вот этот один случай перевешивает любые преимущества.